Comment on ""Multi inflammatory syndrome following first dose of m-RNA COVID-19 vaccination".

Dear Editor, we would like to share ideas on the publications regarding “Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination (Hugh McGann et al., 2022).” Hugh McGann et al. concluded that “We report a 16-year-old male with a multi system inflammatory condition meeting the case definition for MIS following …..evidence of primary infection with SARS-Cov-2. (Hugh McGann et al., 2022).” We agree that there might be a clinical problem following COVID-19 vaccination. In the present case, the multi - inflammatory syndrome might or might not be associated with vaccination. There was an attempt to rule out the other concurrent medical problem that might induce the syndrome. However, there are still some other possible problems. For example, a vaccine recipient might have dengue which is a common cause of multiple inflammatory syndrome (Kebayoon and Wiwanitkit, 2021, Somasetia et al., 2020). Additionally, it is usually difficult to rule out the asymptomatic COVID-19, which might occur pre- or post-vaccination in a COVID-19 vaccine recipient who present abnormal clinical problem.

Declarations

Ethical Approval and Consent to participate: not applicable

Consent for publication: Not appliable

Availability of data and materials: Not applicable

Competing interests: authors are from poor developing country and cannot pay for any charge and ask for full waiving for this correspondence letter

Funding: none

Authors' contributions

Authors contributions

PS 50 % -.

1a Substantial contributions to study conception and design.

1b. Substantial contributions to acquisition of data.

1c. Substantial contributions to analysis and interpretation of data.

2. Drafting the article or revising it critically for important intellectual content.

3. Final approval of the version of the article to be published.

VW 50 % -.

1a Substantial contributions to study conception and design.

1b. Substantial contributions to acquisition of data.

1c. Substantial contributions to analysis and interpretation of data.

2. Drafting the article or revising it critically for important intellectual content.

3. Final approval of the version of the article to be published.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.